Basket | Login

 
 
 
 

Clinical trials by country

Phase II trials

Belgium

  1. AUTONOMY

Czech Republic

  1. TRAILBLAZER-ALZ 2 

Denmark

  1. VIVIAD

Germany

  1. INFRONT-2
  2. INVOKE-2
  3. TRAILBLAZER-ALZ 2 
  4. VIVIAD

Finland

  1. ACI-35-1802

France

  1. AUTONOMY (planned)
  2. INVOKE-2
  3. TRAILBLAZER-ALZ 2 (planned)

Italy

  1. INFRONT-2
  2. INVOKE-2

Netherlands

  1. ACI-35-1802
  2. AUTONOMY (planned)
  3. INFRONT-2
  4. INVOKE-2
  5. TRAILBLAZER-ALZ 2 
  6. VIVIAD

Poland

  1. Brainshuttle AD
  2. INVOKE-2
  3. TRAILBLAZER-ALZ 2

Spain 

  1. AUTONOMY
  2. Brainshuttle AD
  3. INVOKE-2

Sweden

  1. ACO-35-1802 
  2. AUTONOMY 

UK

  1. ACI-35.1802 
  2. AUTONOMY (planned)
  3. DESPIAD
  4. INFRONT-2
  5. INVOKE-2
  6. TRAILBLAZER-ALZ 2 

 

 
 

Last Updated: Monday 18 October 2021

 

 
  • Acknowledgements

    Alzheimer Europe's Clinical Trial Watch received funding under an operating grant from the European Union’s Health Programme (2014–2020).
  • European Union
 
 

Options